Abbott India elevates Maithilee Pathare Mistry as CFO
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Subscribe To Our Newsletter & Stay Updated